New device offers hope for stem cell transplant patients with poor graft function
NCT ID NCT02438904
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study provides compassionate access to a device that selects CD34+ cells (special blood-forming cells) for patients whose stem cell transplant did not work well. The goal is to improve graft function and monitor for graft-versus-host disease. Up to 200 participants will receive this treatment.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BLOOD AND MARROW TRANSPLANTATION are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
University of Texas MD Anderson Cancer Center
RECRUITINGHouston, Texas, 77030, United States